REA Process & Licensing

Facilitating Access to Cutting-Edge Cellular Solutions.

Experience Our Technology Firsthand

At Pluristyx, we believe in the transformative potential of our cellular products, and we want clients to experience their capabilities firsthand. That's why we offer a unique opportunity through our Research Evaluation Agreement, a pathway that grants you access to our gene edited and non-edited cellular products for evaluation, all within our innovative "Try Before You Buy" model. This approach is designed to minimize your upfront financial commitment while maximizing your ability to explore the full potential of our technology. Upon successful evaluation of any of our products Pluristyx has a simplified licensing approach to provide freedom to operate and reduce any barrier to entering the clinic.

Research Evaluation Agreement Process and Licensing

Research Evaluation Licensing process

More Informed Decisions

This approach is a game-changer for researchers and organizations seeking to harness the power of induced Pluripotent Stem Cells (iPSCs). Instead of committing to commercial licensing agreement right away, you have the opportunity to experiment, assess, and witness the results our cellular products and technologies can deliver. Our portfolio of products are designed to aid in the development of allogenic cell based therapies.

It's a risk-limiting strategy that allows you to make informed decisions based on your own firsthand experience and results. Our talented team of scientists are committed to assisting clients through out the entire licensing journey. In 12-18 months you can experience how our technologies can enhance your cell therapy efforts and allow you to develop, Tomorrow's Cell Therapies Today®

Advancing Scientific Innovation

Working with induced Pluripotent Stem Cells (iPSCs) is complex. Leverage our firsthand experience and knowledge to expedite the development of your own cell based product. Our licensing model provides access to our technologies and experience without requiring a large commitment. Begin your relationship with Pluristyx knowing our expertise is based on years of industry experience.

At Pluristyx, we are passionate about advancing the scientific innovation of stem cells, and we want to be your partner on that journey. Our Research Evaluation Agreement and Try Before You Buy approach are clear demonstrations of our commitment to facilitating your access to cutting-edge cellular solutions.

With Pluristyx, you don't just read about the technology; you get to experience it firsthand, making informed decisions that drive your research and development forward. Join us in shaping the future of cellular science and inquiring about licensing our technology today. 

Scientist inspecting cells available for licensing

Explore More

iACT Stealth Cells™

Technology
Our groundbreaking iACT technology with immune-modulatory genes allows the acceptance of allografts without the need for systemic immune suppression. Equipping pluripotent stem cells with this technology will allow the same cell line to be used for differentiation and ultimately transplantation into any individual.
Learn More

Development Services

Solutions
Pluristyx excels at tackling the most challenging aspects of the product lifecycle, giving you the time to concentrate on what you do best.
Learn More

FailSafe®

Technology
A reliable safeguard against transplants becoming tumorigenic – any unwanted cells can be eliminated with a simple source of drug treatment.
Learn More

iACT Stealth Cells™

Technology
Our groundbreaking iACT technology with immune-modulatory genes allows the acceptance of allografts without the need for systemic immune suppression. Equipping pluripotent stem cells with this technology will allow the same cell line to be used for differentiation and ultimately transplantation into any individual.
Learn More

Development Services

Solutions
Pluristyx excels at tackling the most challenging aspects of the product lifecycle, giving you the time to concentrate on what you do best.
Learn More

FailSafe®

Technology
A reliable safeguard against transplants becoming tumorigenic – any unwanted cells can be eliminated with a simple source of drug treatment.
Learn More

Contact us about Licensing today


Shopping Cart
Scroll to Top